Company Search:
Advanced Search
Sponsored Links
Jounce Therapeutics Inc Company Snapshot
Jounce Therapeutics Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jounce Therapeutics Inc with three other companies in this sector in UNITED STATES : Arrowhead Pharmaceuticals Inc (2019 sales of $168.80 million of which 100% was Research & Development), AC Immune SA ($111.79 million of which 100% was Therapeutic and Diagnostic Products), and Radius Health Inc ($173.32 million of which 100% was Drug Manufacturer).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Jounce Therapeutics Inc
  Stock Performance Chart for Jounce Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): 6.94
(Figures in U.S. Dollars)
1 Week -5.7%   13 Weeks -26.9%  
4 Weeks 41.6%   52 Weeks 44.6%  
Jounce Therapeutics Inc Key Data:
  Ticker: JNCE Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 147,872,000
(Year Ending Jan 2020).
Employees: 130
  Currency: U.S. Dollars Market Cap: 237,951,780
  Fiscal Yr Ends: December Shares Outstanding: 34,287,000
  Share Type: Common Closely Held Shares: 9,220,520
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.